Covalon Technologies Ltd. (TSXV:COV)

Market Cap	76.71M
Revenue (ttm)	34.67M
Net Income (ttm)	4.73M
Shares Out	27.40M
EPS (ttm)	0.19
PE Ratio	14.95
Forward PE	58.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,763
Average Volume	39,867
Open	3.200
Previous Close	3.180
Day's Range	2.780 - 3.490
52-Week Range	0.970 - 4.300
Beta	0.66
RSI	36.35
Earnings Date	Jan 27, 2025

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by second...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 37
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: COV